Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size

Exocrine pancreas abnormalities are increasingly recognized as features of type 1 diabetes. We previously reported reduced serum trypsinogen levels and in a separate study, smaller pancreata at and before disease onset. We hypothesized that three pancreas enzymes (amylase, lipase, and trypsinogen) m...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes
Huvudupphovsmän: Ross, James J., Wasserfall, Clive H., Bacher, Rhonda, Perry, Daniel J., McGrail, Kieran, Posgai, Amanda L., Dong, Xiaoru, Muir, Andrew, Li, Xia, Campbell-Thompson, Martha, Brusko, Todd M., Schatz, Desmond A., Haller, Michael J., Atkinson, Mark A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Diabetes Association 2021
Ämnen:
Immunology and Transplantation
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7980193/
https://ncbi.nlm.nih.gov/pubmed/33441381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db20-0995
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk